Quality detection method of Anzi conditioning and brewing soup

Through methanol ultrasonic extraction and liquid chromatography tandem mass spectrometer detection, the shortcomings of Anziqiao Tang quality control were solved, and high-precision and stability detection were achieved, ensuring its effectiveness and safety of treatment.

CN119086768AActive Publication Date: 2024-12-06SHENZHEN MATERNITY & CHILD HEALTHCARE HOSPITAL
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411299337.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-18
Publication Date
2024-12-06
Estimated Expiration
2044-09-18

AI Technical Summary

Technical Problem

The prior art lacks quality control methods for Anzi Gray Chong Decoction, which affects its therapeutic effectiveness and safety.

Method used

The test sample solution was prepared by methanol ultrasonic extraction method, and the test was carried out by liquid chromatography tandem mass spectrometer. The active ingredient content was determined using gradient elution procedures and standard curve method to ensure the precision, repeatability and stability of the detection.

Benefits of technology

The high precision, repeatability and stability detection of Anzijichouchong soup is achieved, ensuring the accuracy and safety of its quality control, with a high recovery rate, and the RSD value is between 2.02% and 8.84%.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119086768A_ABST
    Figure CN119086768A_ABST
Patent Text Reader

Abstract

The invention relates to a quality detection method of an Anzi regulating and brewing decoction, and belongs to the technical field of quality analysis and detection of traditional Chinese medicines. The quality detection method of the Anzi conditioning and brewing soup comprises the following steps: S1, ultrasonically extracting the Anzi conditioning and brewing soup with methanol, and filtering to obtain a test solution; s2, mixing methanol with the active component to obtain a reference solution; s3, detecting the test solution in the step S1 and the reference solution in the step S2 by using a liquid chromatography tandem mass spectrometer; carrying out gradient elution by taking water as a mobile phase A and acetonitrile as a mobile phase B; and S4, according to the relative retention time of the active components in the reference substance solution in the step S2, determining the chromatographic peak of the component to be detected in the test solution, drawing a standard curve according to the peak area and concentration of the reference substance solution in the step S2, and calculating the content of the active components contained in the test solution according to the peak area and the standard curve of the test solution. The method has the advantages of good precision, good repeatability, excellent stability and high accuracy.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of traditional Chinese medicine quality analysis and detection, and in particular to a quality detection method for Anzi Tiao Chong Tang. Background Art

[0002] The Lingnan Luo's gynecology school has significant effects in the prevention and treatment of pregnancy diseases with traditional Chinese medicine. Shenzhen Maternal and Child Health Hospital is the Shenzhen workstation of the Lingnan Luo's gynecology school. Professor Ning Yan, the leader of the discipline, adheres to the treatment advantages and characteristics of Lingnan Luo's gynecology, and combines actual clinical practice to believe that the root cause of immune recurrent miscarriage is kidney deficiency, and the symptom is blood stasis. Therefore, the root cause is treated by tonifying the kidney; the theory of "all diseases are caused by qi" was proposed in "Suwen·Jutonglun". Blood stasis is both the cause and the result. Qi is the leader of blood. Only when qi is sufficient and qi is regulated can the blood flow normally in the blood vessels. Therefore, the symptom is treated by the blood-regulating method of harmonizing qi and blood, and the kidney-regulating method is used as the treatment principle. The experience prescription Anzi Tiaochong Fang (ATF) is summarized for the prevention and treatment of immune recurrent miscarriage, and has obtained a national invention patent (Zl202110229929.1). Considering the climatic characteristics of the Lingnan region, this prescription is based on the basic prescription for nourishing the kidney and calming the fetus, Shoutai Pills, which is in the Qing Dynasty's "Medical Records of Chinese and Western Medicine", and removes the greasy donkey-hide gelatin (reduced-flavor Shoutai Pills), and adds blood-regulating ingredients. Cuscuta, Viscum album, and Dipsacus asper are used to nourish the kidney and improve the essence, consolidate the Chong meridian and calm the fetus. The three medicines are combined as the main medicine; the charcoal made by the charcoal method is used to moderate the effect of promoting blood circulation, and Millettia reticulata is added to promote blood circulation and replenish blood, harmonize the Chong meridian and Ren meridian to nourish the fetus as the minister medicine; ginseng and tangerine peel are used as adjuvants to make the qi and blood biochemical active, and harmonize the qi and blood together with the blood-activating and hemostatic drugs to promote the growth of the fetus. The seven medicines work together to nourish the kidney, regulate the Chong meridian, harmonize the blood and calm the fetus. ATF is used in Shenzhen Maternal and Child Health Hospital in the form of a traditional Chinese medicine decoction for pre-pregnancy conditioning and post-pregnancy fetal maintenance for patients with immune recurrent miscarriage. Preliminary clinical studies have shown that ATF can improve the success rate of fetal maintenance and clinical efficacy, reduce the TCM symptom score, increase the rate of aPL conversion to negative, improve coagulation-fibrinolysis indicators, and has high safety. At present, there is no method for quality control of Anzi Tiao Chong Tang, and a quality detection method for Anzi Tiao Chong Tang needs to be established to ensure its effectiveness and safety in treatment. Summary of the invention

[0003] The purpose of the present invention is to overcome the shortcomings of the prior art and provide a quality detection method for Anzi Tiao Chong Tang with good precision, repeatability and stability and high accuracy.

[0004] To achieve the above object, the technical solution adopted by the present invention is:

[0005] A quality detection method for Anzi Tiao Chong Tang comprises the following steps:

[0006] S1: Ultrasonic extraction of Anzitiao Chong decoction with methanol, filtration, and obtaining the test solution;

[0007] S2: Mixing methanol with the active ingredient to obtain a reference solution; the active ingredient is at least one of astragaloside, radix scutellariae glycosides, radix scutellariae glycosides, radix scutellariae glycosides VI, typhalaenosides, ginsenoside Rg1, ginsenoside Rf, ginsenoside Rb1, ginsenoside Rb2, ginsenoside Rc, ginsenoside Rd, hesperidin, nobiletin, naringin, meditartin, catechin, epicatechin, formononetin, formononetin, daidzein, rutin, β-sitosterol and glycyrrhizin;

[0008] S3: Detect the test solution of step S1 and the reference solution of step S2 using a liquid chromatography tandem mass spectrometer; use water as mobile phase A and acetonitrile as mobile phase B to perform gradient elution, and the gradient elution program is:

[0009] 0-10min, the volume concentration of mobile phase A is 85%-88%, and the volume concentration of mobile phase B is 12%-15%; 10-52min, the volume concentration of mobile phase A is 67%-85%, and the volume concentration of mobile phase B is 15%-33%; 52-72min, the volume concentration of mobile phase A is 64%-67%, and the volume concentration of mobile phase B is 33%-36%; 72-80min, the volume concentration of mobile phase A is 56%-64%, and the volume concentration of mobile phase B is 36%-44%;

[0010] S4: according to the relative retention time of the active ingredient in the reference solution of step S2, determine the chromatographic peak of the component to be tested in the test solution, make a standard curve according to the peak area and concentration of the reference solution of step S2, and calculate the content of the active ingredient contained in the test solution according to the peak area of ​​the test solution and the standard curve;

[0011] The Anzi Tiao Chong decoction is composed of salt dodder seeds, mistletoe, dipsaci, millettia reticulata, pollen charcoal, ginseng and tangerine peel.

[0012] The method of the invention has good precision, repeatability and stability and high accuracy.

[0013] Furthermore, the flow rate was 0.2 ml / min.

[0014] Furthermore, the column temperature was 30°C.

[0015] Furthermore, the chromatographic column is a Waters XSelect HSS T3 column, and the chromatographic column specifications are: column length 150 mm, inner diameter 2.1 mm, particle size 3.5 μm.

[0016] Furthermore, the injection volume was 1 μl.

[0017] Furthermore, the volume concentration of methanol in step S1 is 50%.

[0018] Furthermore, the methanol ultrasonic treatment time in step S1 is 30 min.

[0019] Furthermore, the methanol in step S2 is mass spectrometry grade methanol.

[0020] Furthermore, the mass spectrometry conditions were: electrospray ionization source, scanning mode was multi-stage reaction monitoring mode, positive and negative ion scanning mode, nebulizing gas flow rate was 3.0 l / min, drying gas flow rate was 10.0 l / min, heating gas flow rate was 10.0 l / min, and detector voltage was 1.88 kV.

[0021] Furthermore, the relative retention time of astragaloside was 26.479 min; the relative retention time of scutellaria baicalensis glycoside was 26.038 min; the relative retention time of dandelion glycoside was 9.862 min; the relative retention time of chuanxiong saponin VI was 51.677 min; the relative retention time of typha galangin was 18.489 min; the relative retention time of ginsenoside Rg1 was 35.176 min; the relative retention time of ginsenoside Rf was 49.757 min; the relative retention time of ginsenoside Rb1 was 56.225 min; the relative retention time of ginsenoside Rb2 was 60.886 min; the relative retention time of ginsenoside Rc was 58.356 min; the relative retention time of ginsenoside Rd was 67.053 min. min; the relative retention time of hesperidin is 27.889min; the relative retention time of nobiletin is 71.493min; the relative retention time of naringin is 24.676min; the relative retention time of mediptertin is 68.481min; the relative retention time of catechin is 7.067min; the relative retention time of epicatechin is 10.523min; the relative retention time of formononetin is 32.294min; the relative retention time of formononetin is 57.858min; the relative retention time of daidzin is 13.86min; the relative retention time of rutin is 20.283min; the relative retention time of β-sitosterol is 28.699min; the relative retention time of liquiritigenin is 36.488min.

[0022] Further, in the reference solution, the concentration of astragaloside was 17.6000 μg / ml, the concentration of scutellaria baicalensis was 10.4500 μg / ml, the concentration of daunoside was 21.1000 μg / ml, the concentration of chuanxiong saponin VI was 14.8500 μg / ml, the concentration of typha scoparia was 13.3500 μg / ml, the concentration of ginsenoside Rg1 was 35.4500 μg / ml, the concentration of ginsenoside Rf was 20.4500 μg / ml, the concentration of ginsenoside Rb1 was 15.9500 μg / ml, the concentration of ginsenoside Rb2 was 35.1000 μg / ml, the concentration of ginsenoside Rc was 23.6000 μg / ml, and the concentration of ginsenoside Rd was 15.55 00μg / ml, hesperidin concentration was 4.4670μg / ml, nobiletin concentration was 21.9500μg / ml, naringin concentration was 11.5000μg / ml, mediptertin concentration was 8.4000μg / ml, catechin concentration was 14.9790μg / ml, epicatechin concentration was 20.4880μg / ml, formononetin concentration was 16.4750μg / ml, formononetin concentration was 9.5000μg / ml, daidzein concentration was 8.2400μg / ml, rutin concentration was 9.2500μg / ml, β-sitosterol concentration was 4.0400μg / ml, and liquiritigenin concentration was 4.4000μg / ml.

[0023] Compared with the prior art, the present invention has the following beneficial effects:

[0024] The invention constructs a quality control method for Anzitiao Chongtang, and the method has good precision, RSD < 5.00%; good repeatability, RSD between 2.96% and 6.63%; excellent stability, RSD value between 2.77% and 12.28%; high accuracy, recovery rate between 97.98% and 107.93%, and RSD value between 2.02% and 8.84%.

[0025] The present invention also analyzes the components of Anzi Tiao Chong Tang and the targets and related pathways of recurrent spontaneous abortion combined with antiphospholipid syndrome (APS / RSA), clarifies the important quality markers of ATF for treating APS / RSA, namely, glycyrrhizin, nobiletin, ginsenoside Rb1 and astragaloside, and through the binding affinity analysis of 4 quality markers and 5 core targets, it is found that the top 5 molecules with the highest binding force are albumin and glycyrrhizin, tumor necrosis factor and astragaloside, signal transducer and activator of transcription 3 and ginsenoside Rb1, interleukin-6 and glycyrrhizin, and vascular endothelial growth factor A and ginsenoside Rb1. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 HPLC-MS / MS analysis of 23 active ingredients.

[0027] Figure 2 The total ion current diagram of the chemical components that may be detected in the preliminary screening of Anzi Tiao Chong Tang. A is the mixed reference; B is Anzi Tiao Chong Tang; 1: catechin; 2: epicatechin; 3: daidzein; 4: typhaneoglycans; 5: rutin; 6: hyperoside; 7: isoquercitrin; 8: dangyao glycoside; 9: naringin; 10: rutin; 11: β-sitosterol; 12: astragaloside; 13: naringin; 14: hesperidin; 15: neohesperidin; 16: ginsenoside Rg1; 17: miscanthus glycoside; 18: Ginsenoside VI; 19: Licorice root; 20: Calycosin; 21: Quercetin; 22: Dipsacoside VI; 23: Ginsenoside Rf; 24: Ginsenoside Rb1; 25: Ginsenoside Rc; 26: Ginsenoside Rb2; 27: Kaempferol; 28: Isorhamnetin; 29: Ginsenoside Rd; 30: Formononetin; 31: Meditanin; 32: Nobiletin.

[0028] Figure 3 This is a Venn diagram of the targets of ATF and APS / RSA.

[0029] Figure 4 It is the enrichment analysis of the target. A is the enrichment analysis of the top 20 GO biological processes; B is the enrichment analysis of the top 20 Reactome pathways. The size of the bubble indicates the number of enriched targets. The redder the color, the smaller the P value, and the bluer the color, the larger the P value.

[0030] Figure 5 It is the prescription-TCM-ingredient-disease-target-pathway interaction network (green ovals represent prescriptions, blue hexagons represent TCMs, yellow parallelograms represent compound ingredients, orange prisms represent diseases, pink triangles represent targets, and red V-shapes represent pathways).

[0031] Figure 6 The molecular docking diagrams of the top five molecules with the highest binding force are shown in Figure 1. A is albumin and liquiritigenin; B is tumor necrosis factor and astragaloside; C is signal transducer and activator of transcription 3 and ginsenoside Rb1; D is interleukin-6 and liquiritigenin; and E is vascular endothelial growth factor A and ginsenoside Rb1. DETAILED DESCRIPTION

[0032] To better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific examples. Other materials, reagents, etc. used in the examples, unless otherwise specified, can be obtained from commercial sources.

[0033] 1. Instrument

[0034] Shimadzu LC-MS8045 liquid spectrometer, EP225SM-DR 1 / 100000 analytical balance (Plissex, Switzerland), A3S-10-10-CE ultrapure water machine (Aicopur International, USA), KQ5200DE CNC ultrasonic cleaner (Kunshan Shumei Ultrasonic Instrument Co., Ltd.).

[0035] 2. Reagents and test drugs

[0036] Astragaloside (batch number: wkq21020405, 99.02%), scutellariae glycoside (batch number: wkq21092702, 99.48%), swertiacoside (batch number: wkq21060110, 99.53%), chuanxiong saponin VI (batch number: wkq21121705, 99.45%), typhalaenoside (batch number: wkq21070205, 99.14%), ginsenoside Rg1 (batch number: wkq21020401, 98.5%) , ginsenoside Rf (batch number: wkq21071605, 98.53%), ginsenoside Rb1 (batch number: wkq21122303, 98.69%), ginsenoside Rb2 (batch number: wkq21062404, 99.61%), ginsenoside Rc (batch number: wkq21052411, 98.18%), ginsenoside Rd (batch number: wkq21042607, 98.83%), hesperidin (batch number: wkq21020906 , 99.34%), nobiletin (batch number: wkq21030909, 99.69%), naringin (batch number: wkq21042602, 99.86%), meditartin (batch number: wkq21083008, 99.24%), catechin (batch number: wkq21112304, 99.45%), epicatechin (batch number: wkq21090706, 98.01%), formononetin (batch number: wkq21070703, 9 9.69%), glycyrrhizin (batch number: wkq21032002, 99.27%), β-sitosterol (batch number: wkq21072209, 99.67%) were purchased from Sichuan Weikeqi Biotechnology Co., Ltd.; formononetin (batch number: 111703-201504), daidzein (batch number: 111738-201603, 93.3%), and rutin (batch number: 100080-201811, 91.7%) were purchased from China Food and Drug Inspection Institutes. Acetonitrile, methanol (mass spectrometry grade, Merck), and ultrapure water (homemade).

[0037] Example 1 A method for detecting the active ingredients of Anzi Tiao Chong Fang (ATF)

[0038] 1. Preparation of reference substances and samples

[0039] (1) Preparation of reference solution

[0040] Accurately weigh appropriate amounts of astragaloside, radix scutellariae glycoside, radix scutellariae glycoside, radix scutellariae saponin VI, typhala glycoside, ginsenoside Rg1, ginsenoside Rf, ginsenoside Rb1, ginsenoside Rb2, ginsenoside Rc, ginsenoside Rd, hesperidin, nobiletin, naringin, meditartin, catechin, epicatechin, formononetin, formononetin, daidzein, rutin, β-sitosterol and glycyrrhizin (a total of 23 active ingredients), add methanol and ultrasonically dissolve to prepare solutions with mass concentrations of 1.7600 mg / ml, 1.0450 mg / ml, 2.1100 mg / ml, 1.4850 mg / ml, 1.3350 mg / ml, 3.5 Single reference substance stock solutions of 450mg / ml, 2.0450mg / ml, 1.5950mg / ml, 3.5100mg / ml, 2.3600mg / ml, 1.5550mg / ml, 0.4467mg / ml, 2.1950mg / ml, 1.1500mg / ml, 0.8400mg / ml, 1.4979mg / ml, 2.0488mg / ml, 1.6475mg / ml, 0.9500mg / ml, 0.8240mg / ml, 0.9250mg / ml, 0.2020mg / ml and 0.2200mg / ml are prepared for use.

[0041] Accurately measure appropriate amounts of the above-mentioned single reference substance stock solutions, place them in the same volumetric flask, add mass spectrometry grade methanol (volume concentration 99.9%) to the scale, and obtain astragaloside 17.6000μg / ml, radix scutellariae glycoside 10.4500μg / ml, dangyao glycoside 21.1000μg / ml, chuanxiong saponin VI 14.8500μg / ml, typha glycoside 13.3500μg / ml, ginsenoside Rg 135.4500μg / ml, ginsenoside Rf 20.4500μg / ml, ginsenoside Rb 115.9500μg / ml, ginsenoside Rb2 35.1000μg / ml, ginsenoside Rc 23.6000μg / ml, ginsenoside Rd A mixed reference solution of 15.5500μg / ml, hesperidin 4.4670μg / ml, nobiletin 21.9500μg / ml, naringin 11.5000μg / ml, mediptertin 8.4000μg / ml, catechin 14.9790μg / ml, epicatechin 20.4880μg / ml, formononetin 16.4750μg / ml, formononetin 9.5000μg / ml, daidzin 8.2400μg / ml, rutin 9.2500μg / ml, β-sitosterol 4.0400μg / ml, and glycyrrhizin 4.4000μg / ml.

[0042] (2) Preparation of test solution

[0043] The ATF formula is composed of 12 parts of salt dodder seeds, 6 parts of mistletoe, 6 parts of knotweed, 12 parts of millettia reticulata, 5 parts of pollen charcoal, 4 parts of ginseng and 4 parts of tangerine peel, by weight.

[0044] Weigh each medicinal material in the ATF formula and soak it in water for 12 hours. The weight ratio of water to medicinal materials is 10:1. Decoction for 1 hour, filter, and obtain the filtrate. Decoction twice more in the same way, combine the filtrates three times, and concentrate under reduced pressure to a concentration of 0.98g / ml to obtain Anzi Tiao Chong Tang.

[0045] Accurately measure 0.4 ml of Anzitiao Chong Tang, place it in a 10 ml volumetric flask, add 50% (v / v) methanol to the scale line, ultrasonically extract for 30 min, let it cool to room temperature, make up to volume with 50% (v / v) methanol, shake well, centrifuge, and filter with a 0.22 μm microporous filter membrane to obtain the test solution.

[0046] 2. Chromatographic and mass spectrometry conditions

[0047] (1) Chromatographic conditions

[0048] Chromatographic column: Waters XSelect HSS T3 column (2.1*150 mm, 3.5 μm) with a column length of 150 mm, an inner diameter of 2.1 mm, and a particle size of 3.5 μm.

[0049] Mobile phase: water (phase A), acetonitrile (phase B).

[0050] Gradient elution program:

[0051] 0-10min, 12%-15% (Phase B), 85%-88% (Phase A);

[0052] 10-52 min, 15%-33% (Phase B), 67%-85% (Phase A);

[0053] 52-72 min, 33%-36% (phase B), 64%-67% (phase A);

[0054] 72-80 min, 36%-44% (phase B), 56%-64% (phase A);

[0055] The percentages of phase A and phase B are volume concentrations.

[0056] Flow rate: 0.2 ml / min; column temperature: 30°C; injection volume: 1 μl.

[0057] (2) Mass spectrometry conditions

[0058] The electrospray ionization source (ESI) was used, the scanning mode was multiple reaction monitoring (MRM), the positive and negative ion scanning mode, the nebulizer gas flow rate was 3.0 l / min, the drying gas flow rate was 10.0 l / min, the heating gas flow rate was 10.0 l / min, and the detector voltage was 1.88 kV.

[0059] 3. Results Analysis

[0060] A standard curve is made based on the peak area and concentration of the mixed reference solution, and the content of the active ingredient in the test solution is calculated based on the peak area of ​​the test solution and the standard curve.

[0061] The detection parameters of the 23 active ingredients are shown in Table 1, and the HPLC-MS / MS analysis of the 23 active ingredients is shown in Figure 1 shown.

[0062] Table 1 Detection parameters of 23 active ingredients

[0063]

[0064]

[0065] Example 2 Linear Range

[0066] 1. Experimental Methods

[0067] Take the reference stock solutions of 20 active ingredients in Example 1, including astragaloside, radix scutellariae glycosides, radix scutellariae glycosides, radix scutellariae saponins VI, typhala glycosides, ginsenoside Rg1, ginsenoside Rf, ginsenoside Rb1, ginsenoside Rb2, ginsenoside Rc, hesperidin, nobiletin, naringin, meditartin, catechin, epicatechin, formononetin, formononetin, daidzin and rutin, and dilute them with methanol to prepare a mixed solution with gradient concentration. The measurement was carried out according to the method of Example 1, with the abscissa being the mass concentration (x, μg / ml) and the ordinate peak being the area (y). Standard curves were drawn to obtain regression equations.

[0068] 2. Experimental Results

[0069] Through regression analysis, a linear relationship between the peak area and concentration of each standard compound was established. The horizontal axis represents the ratio of the concentration of each standard to the internal standard, and the vertical axis represents the ratio of the peak area of ​​each standard to the peak area of ​​the internal standard. Each calibration curve has good linearity in a wide concentration range, and the correlation coefficient is 0.9963±0.002645. The regression equation, correlation coefficient, linear range, quantitative limit and detection limit of each compound are shown in Table 2. The 20 calibration curves show a good linear relationship between the peak area and the concentration (r>0.9914).

[0070] Table 2 Linear range results of 20 active ingredients

[0071]

[0072] Example 3 Precision, Repeatability, Stability and Sample Recovery

[0073] 1. Experimental Methods

[0074] According to the method of Example 1, a mixed reference solution of 20 active ingredients including astragaloside, radix scutellariae glycosides, radix scutellariae glycosides, radix scutellariae saponins VI, typhalaenosides, ginsenoside Rg1, ginsenoside Rf, ginsenoside Rb1, ginsenoside Rb2, ginsenoside Rc, hesperidin, nobiletin, naringin, meditartin, catechin, epicatechin, formononetin, formononetin, daidzin and rutin was prepared.

[0075] 1. Precision: According to the method of Example 1, the test solution was sampled and tested six times in succession, the peak area of ​​each component to be tested was recorded and the relative standard deviation (RSD) was calculated.

[0076] 2. Stability: According to the method of Example 1, the test solution was sampled and measured at 0, 3, 6, 9, and 12 h, and the peak area of ​​each component to be tested was recorded and the RSD was calculated.

[0077] 3. Repeatability: According to the method of Example 1, 6 test solutions were prepared in parallel, sampled and tested, and the peak area of ​​each component to be tested was recorded and the RSD was calculated.

[0078] 4. Sample recovery: Take 0.2 ml of 6 portions of Anzitiao Chongtang with known content, add each reference solution prepared in Example 1 at a mass ratio of 1:1, and recover the sample to be tested. Take 0.4 ml of the sample to recover the sample to be tested, and test according to the method of Example 1 to calculate the sample recovery rate of each component to be tested.

[0079] 2. Experimental Results

[0080] The experimental results are shown in Table 3.

[0081] The concentrations of 20 compounds in the mixed standard solution were measured twice a day to evaluate the precision, and the experiment was continued for 3 days to evaluate the variability. The RSD (n=6) of the precision test of each component was less than 5.0%, indicating that the precision of this method is good.

[0082] For the stability analysis of the sample solution, the RSD values ​​at room temperature for 0, 2, 4, 8, and 12 hours were 2.77% to 12.28%. The RSD (n=5) of the stability test was less than or equal to 12.28%, indicating that the test solution was relatively stable within 12 hours at room temperature.

[0083] Six solutions were measured repeatedly on one day, and the RSD was between 2.96% and 6.63%, which was less than 10.0%, indicating that the repeatability of this method was good.

[0084] The recovery rate of sample addition recovery is between 97.98% and 107.93%, and the relative deviation is less than 8.84%.

[0085] Table 3 Precision, repeatability, stability and recovery test results of 20 active ingredients

[0086]

[0087]

[0088] Example 4 Actual sample determination

[0089] 1. Experimental Methods

[0090] According to the method of Example 1, the content of Anzitiao Chongtang in three batches (20220415-01, 20220415-02 and 20220415-03) was detected.

[0091] 2. Experimental Results

[0092] The concentrations of 20 active ingredients in different samples are shown in Table 4, among which the content of Dipsacus asper saponin VI was the highest, which was 8627.0909±165.7464 μg / ml.

[0093] Table 4 Determination results of the contents of 20 active ingredients

[0094]

[0095]

[0096] Example 5 Determination of the active ingredients to be tested in Anzitiao Chongtang

[0097] 1. Experimental Methods

[0098] According to the prescription medicinal composition of Anzi Tiao Chong Tang and the results of literature research, 32 chemical components that may be detected in Anzi Tiao Chong Tang were preliminarily screened out, as shown in Table 5. The detection was carried out under the same chromatographic conditions and mass spectrometry conditions as in Example 1.

[0099] Table 5 Preliminary screening of chemical components that may be detected in Anzitiao Chongtang

[0100]

[0101] 2. Experimental Results

[0102] Seven chemical components, including naringin, neohesperidin, ginsenoside VI, calycosin isoflavones, quercetin, kaempferol and isorhamnetin, were not detected in Anzi Tiao Chong Tang. Two chemical components, hyperoside and isoquercetin, were detected. However, due to the similar polarity of these two chemical components, the separation degree did not meet the detection requirements after changing the elution gradient of different mobile phases. Therefore, 23 target components were finally determined to be detected, among which β-sitosterol, ginsenoside Rd and licorice were at low contents and were tentatively determined as qualitative identification. The other 20 target components were determined as quantitative detection. The total ion current of the chemical components that may be detected in the preliminary screening of Anzi Tiao Chong Tang is shown in Figure 2 .

[0103] Example 6 Determination of Chromatographic Conditions

[0104] 1. Experimental Methods

[0105] 1. The influence of different mobile phase systems on the detection results

[0106] The experiments were conducted with three different mobile phase systems: (1) acetonitrile (phase B)-water (phase A), (2) acetonitrile (phase B)-0.02% (w / v) formic acid solution (phase A), and (3) acetonitrile (phase B)-5 mM ammonium acetate solution (phase A). Other detection methods were the same as those in Example 1.

[0107] 2. The influence of different chromatographic columns on the test results

[0108] Two chromatographic columns, Thermo hypersil GOLD C18 (4.6*150mm, 5μm) with a column length of 150mm, an inner diameter of 4.6mm, and a particle size of 5μm and Waters XSelect HSS T3 (2.1*150mm, 3.5μm), were selected for the experiment. Other detection methods were the same as in Example 1.

[0109] 3. Effect of different elution gradients on detection results

[0110] Using water (phase A)-acetonitrile (phase B) as the mobile phase system, different elution gradients were selected for detection:

[0111] Elution gradient 1: [0-30 min, 10%-80% (phase B), 20%-90% (phase A)];

[0112] Elution gradient 2: [0-30 min, 15%-60% (phase B), 40%-85% (phase A)];

[0113] Elution gradient 3: [0-20 min, 12%-16% (phase B), 84%-88% (phase A); 20-50 min, 16%-25% (phase B), 75%-84% (phase A); 50-60 min, 25%-40% (phase B), 60%-75% (phase A)];

[0114] Elution gradient 4: [0-10 min, 12%-15% (phase B), 85%-88% (phase A); 10-40 min, 15%-35% (phase B), 65%-85% (phase A); 40-80 min, 35%-50% (phase B), 50%-65% (phase A)];

[0115] Elution gradient 5: [0-10 min, 12%-15% (phase B), 85%-88% (phase A); 10-52 min, 15%-33% (phase B), 67%-85% (phase A); 52-72 min, 33%-36% (phase B), 64%-67% (phase A); 72-80 min, 36%-44% (phase B), 56%-64% (phase A)].

[0116] Other detection methods are the same as those in Example 1. The percentage contents of phase A and phase B are volume concentrations.

[0117] 2. Experimental Results

[0118] 1. When acetonitrile (B phase)-water (A phase) is used as the mobile phase system, the sensitivity, response value, peak shape and separation of each target component are better than those when acetonitrile (B phase)-0.02% (w / v) formic acid solution (A phase) and acetonitrile (B phase)-5mM ammonium acetate solution (A phase) are used as the mobile phase system. Since the ion addition mode of typhanoside, rutin, naringin, rutin, astragaloside, hesperidin, liquiritigenin and formononetin is [MH] - The ion addition mode of ginsenoside Rg1, ginsenoside Rf, ginsenoside Rb1, ginsenoside VI, ginsenoside Rc, ginsenoside Rb2 and ginsenoside Rd is [M+Na] +When acetonitrile (phase B)-0.02% (w / v) formic acid solution (phase A) was used as the mobile phase system, the ionization of these target components was suppressed, and the sensitivity and response values ​​were low. When acetonitrile (phase B)-5 mM ammonium acetate solution (phase A) was used as the mobile phase system, the ion addition mode of target components such as catechins, epicatechin and daidzein was [M+H] + , ionization is suppressed, sensitivity and response value are low, so acetonitrile (B phase)-water (A phase) is selected as the mobile phase system of the present invention.

[0119] 2. When Waters XSelect HSS T3 (2.1*150mm, 3.5μm) is used as the chromatographic column, the peak shape and separation of each target component are more ideal than those of Thermo hypersil GOLD C18 (4.6*150mm, 5μm).

[0120] 3. When the mobile phase elution gradient is 5, the separation degree of each target component is better than that of elution gradients 1 to 4.

[0121] Example 7 Prediction of ATF targets, related pathways, and binding to APS / RSA targets

[0122] 1. Experimental Methods

[0123] 1. Predict the target sites of ATF-identified ingredients: The target sites of the Chinese herbal medicine ingredients identified by HPLC-MS / MS were predicted in the HERB (http: / / herb.ac.cn / ), simILarity ensemble approach (https: / / sea.bkslab.org / ), PharmMapper (http: / / www.lILab-ecust.cn / pharmmapper / ) and Swiss Target Prediction (http: / / www.swisstargetprediction.ch / ) databases, and the prediction results were merged.

[0124] 2. Screening targets for recurrent spontaneous abortion combined with antiphospholipid syndrome (APS / RSA)

[0125] The Gene Expression Omnibus (GEO) database (https: / / www.ncbi.nlm.nih.gov / geo / ) provides functional genomic data, including gene expression data, chips, and microarrays. This paper selected humans as the analysis object, using the data sets GSE22490 and GSE121950, which included samples from recurrent spontaneous abortion and induced abortion (IA) cases. The limma package of R language was used to filter the differentially expressed genes (DEGs) between RSA and IA, and DEGs with P < 0.05 were considered statistically significant.

[0126] The keywords "recurrent pregnancy loss", "recurrent spontaneous abortion", "recurrent abortion" and "recurrent miscarriage" were used to search for recurrent miscarriage-related targets on Genecards (https: / / www.genecards.org / ) to identify disease targets for recurrent miscarriage. In addition, the keyword "antiphospholipid syndrome" was used to search for antiphospholipid syndrome-related targets. Finally, DisGeNET (v7.0) (https: / / www.disgenet.org / ) was used to search for recurrent miscarriage-related targets using the keywords "recurrent pregnancy loss" and "recurrent spontaneous abortion".

[0127] 3. Screening of targets for ATF in the treatment of APS / RSA

[0128] First, the DEGs with P < 0.05 obtained in the GEO database and the targets retrieved in the Genecards and DisGeNET databases were merged, and then merged with the searched antiphospholipid syndrome-related targets to obtain the targets related to APS / RSA. The compound targets predicted in step 1 were intersected with the disease targets, which were the potential targets of ATF for the treatment of APS / RSA, and were imported into jvenn (http: / / www.bioinformatics.com.cn / static / others / jvenn / example.html) and represented in the form of a Venn diagram.

[0129] 4. Gene Ontology (GO) enrichment analysis and Reactome pathway analysis

[0130] Select the species as "Homo sapiens (humans)", the input method as "gene symbol", and the significance level analysis target of P < 0.05. Use KOBAS-I (http: / / kobas.cbi.pku.edu.cn / ) to perform gene ontology enrichment analysis and Reactome pathway analysis on the potential targets screened in step 3. Import the top 20 results of the two analyses into the bioinformatics website (http: / / www.bioinformatics.com.cn / ) for visualization. Select the potential targets involved in the top 20 Reactome pathway analysis results, and construct a protein-protein interaction (PPI) network in the STRING database (https: / / cn.string-db.org / ). Set the species to "Homo sapiens" and the minimum required interaction score to "highest confidence (>0.4)".

[0131] 5. Construction of the prescription-TCM-ingredient-disease-target-pathway network of Anzi Tiaochong prescription for the treatment of recurrent spontaneous abortion combined with antiphospholipid syndrome

[0132] The interaction network of prescriptions, Chinese medicines, ingredients, diseases, targets and pathways was constructed using Cytoscape 3.9.1 software. Each element is represented by a node in the network diagram, and the relationship between them is represented by an edge. The topological characteristics of the network were analyzed using the Cytoscape software network analysis plug-in. Quality markers were scored according to the number of nodes in the network, which is a direct way to characterize the importance of nodes in network analysis.

[0133] 6. Molecular docking

[0134] Although the possible relationship between the chemical components of traditional Chinese medicine and the targets has been predicted before, the exact role of their interaction remains unclear. In order to further verify the accuracy of the prediction, computer-assisted molecular docking technology was applied to verify the binding interaction between them. According to step 5, the four active ingredients with the highest number of nodes were obtained, and the five core targets with the highest number of nodes were determined. The data of protein receptors were downloaded from the RCSB protein database (Protein Data Bank, PDB, https: / / www.rcsb.org / ). The protein structure was imported into AutoDockTools 1.5.7, and hydrogenation, charge calculation, charge assignment, and atomic type assignment were performed before saving in the "pdbqt" format. The small molecule compounds with 3D structures in SDF format need to be downloaded from the PubChem (https: / / pubchem.ncbi.nlm.nih.gov) database and imported into ChemBio3D Ultra 14.0, and the Minimum RMS Gradient was set to: 0.001 to minimize the energy. Subsequently, the small molecule compounds were saved in mol2 format. We imported the optimized small molecule compounds into AutodockTools1.5.7 for hydrogenation, charge calculation, charge assignment, and rotatable bond setting, and then saved them in the "pdbqt" format. AutoDock Vina 1.2.5 was used to simulate the docking of proteins with their corresponding compounds. PyMol 2.5 was used to analyze the docking results and determine the interaction mode.

[0135] 2. Experimental Results

[0136] 1. Predict the results of potential targets: By constructing a Venn diagram on the jvenn website ( Figure 3 ), as can be seen from the figure, 942 targets of 23 ATF compounds were screened, 132 disease targets related to recurrent spontaneous abortion combined with antiphospholipid syndrome were obtained, and 42 potential targets of ATF for the treatment of APS / RSA were obtained.

[0137] 2. Enrichment analysis of potential targets of ATF in the treatment of APS / RSA

[0138] like Figure 4 As shown in A, GO enrichment analysis of potential targets was performed. Among the top 20 enriched biological processes (BPs), the main ones are cytokine-mediated signaling pathways, negative regulation of apoptosis, positive regulation of angiogenesis, and inflammatory response. Figure 4B visualizes the top 20 pathways of the Reactome pathway analysis of potential targets. The 42 targets are mainly related to signaling pathways such as the immune system, immune system cytokine signaling, interleukin signaling, platelet activation, signal transduction and aggregation, and VEGF signaling. This result suggests that Anzi Tiao Chong Fang may effectively treat APS / RSA through multiple signaling pathways that interact in a complex manner. It is worth noting that the top 20 Reactome pathways are enriched with 39 potential targets.

[0139] 3. ATF prescription-TCM-ingredient-disease-target-pathway network for the treatment of APS / RSA

[0140] Figure 5 The prescription-TCM-ingredient-disease-target-pathway interaction network was displayed, which included 91 nodes (1 prescription, 7 TCMs, 23 active compounds, 1 disease, 39 potential targets, and the top 20 Reactome pathways) and 799 edges. The network summarized the characteristics of variability and complexity of TCM prescription functions and clarified the mechanism of ATF in treating APS / RSA with multiple components, multiple targets, and multiple pathways. It is worth noting that the top four active compounds, namely liquiritigenin, nobiletin, ginsenoside Rb1, and astragaloside, are important quality markers for ATF in treating APS / RSA. These quality markers may affect not only a single target, but the entire biological network system. The number of nodes for liquiritigenin, nobiletin, ginsenoside Rb1, and astragaloside are 13, 13, 12, and 10, respectively. The top five targets with the highest number of nodes among the 39 potential targets are core targets, namely vascular endothelial growth factor A (VEGFA), tumor necrosis factor (TNF), interleukin-6 (IL-6), albumin (ALB), and signal transducer and activator of transcription 3 (STAT3). The number of nodes for these targets is 59, 50, 47, 43, and 42, respectively. The relevant information is shown in Table 6.

[0141] Table 6 Detailed information of core action targets

[0142]

[0143] 4. Molecular docking results

[0144] The binding affinities of the four quality markers to the five core targets were all <-5 kcal / mol, as shown in Table 7. The top five molecules with the highest binding affinity were albumin to liquiritigenin, tumor necrosis factor to astragaloside, signal transducer and activator of transcription 3 to ginsenoside Rb1, interleukin-6 to liquiritigenin, and vascular endothelial growth factor A to ginsenoside Rb1, as shown in Figure 6 A~ Figure 6 E. The binding energy between albumin and licorice is the lowest, which is -10.0 kcal / mol, indicating that there is a good binding interaction between the two. They interact mainly through the formation of hydrogen bonds and hydrophobic forces, forming hydrogen bonds with AlA-158, and the length of the hydrogen bond is It has hydrophobic interaction with GlY-189, lEU-154, ILE-142, lEU-139, TYR-138, lEU-135 and TYR-161.

[0145] Table 7 Binding affinity of 4 quality markers to 5 core targets

[0146]

[0147] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.

Claims

1. A quality testing method for Anzi Tiao Chong Tang, characterized in that: The following steps are included: S1: Ultrasonic extraction of Anzitiao Chong decoction with methanol, filtration, and obtaining the test solution; S2: Mixing methanol with the active ingredient to obtain a reference solution; the active ingredient is at least one of astragaloside, radix scutellariae glycosides, radix scutellariae glycosides, radix scutellariae glycosides VI, typhalaenosides, ginsenoside Rg1, ginsenoside Rf, ginsenoside Rb1, ginsenoside Rb2, ginsenoside Rc, ginsenoside Rd, hesperidin, nobiletin, naringin, meditartin, catechin, epicatechin, formononetin, formononetin, daidzein, rutin, β-sitosterol and glycyrrhizin; S3: Detect the test solution of step S1 and the reference solution of step S2 using a liquid chromatography tandem mass spectrometer; use water as mobile phase A and acetonitrile as mobile phase B to perform gradient elution, and the gradient elution program is: 0-10min, the volume concentration of mobile phase A is 85%-88%, and the volume concentration of mobile phase B is 12%-15%; 10-52min, the volume concentration of mobile phase A is 67%-85%, and the volume concentration of mobile phase B is 15%-33%; 52-72min, the volume concentration of mobile phase A is 64%-67%, and the volume concentration of mobile phase B is 33%-36%; 72-80min, the volume concentration of mobile phase A is 56%-64%, and the volume concentration of mobile phase B is 36%-44%; S4: according to the relative retention time of the active ingredient in the reference solution of step S2, determine the chromatographic peak of the component to be tested in the test solution, make a standard curve according to the peak area and concentration of the reference solution of step S2, and calculate the content of the active ingredient contained in the test solution according to the peak area of ​​the test solution and the standard curve; The Anzi Tiao Chong decoction is composed of salt dodder seeds, mistletoe, dipsaci, millettia reticulata, pollen charcoal, ginseng and tangerine peel.

2. The quality inspection method according to claim 1, characterized in that: The flow rate is 0.2 ml / min.

3. The quality inspection method according to claim 1, characterized in that: The column temperature was 30°C.

4. The quality inspection method according to claim 1, characterized in that: The chromatographic column is a Waters XSelect HSST3 column, and the specifications of the chromatographic column are: column length 150 mm, inner diameter 2.1 mm, and particle size 3.5 μm.

5. The quality inspection method according to claim 1, characterized in that: The injection volume was 1 μl.

6. The quality inspection method according to claim 1, characterized in that: The volume concentration of methanol in step S1 is 50%.

7. The quality inspection method according to claim 1, characterized in that: The methanol in step S2 is mass spectrometry grade methanol.

8. The quality inspection method according to claim 1, characterized in that: The mass spectrometry conditions were as follows: electrospray ionization source, scanning mode was multi-stage reaction monitoring mode, positive and negative ion scanning mode, nebulizing gas flow rate was 3.0 l / min, drying gas flow rate was 10.0 l / min, heating gas flow rate was 10.0 l / min, and detector voltage was 1.88 kV.

9. The quality inspection method according to claim 1, characterized in that: The relative retention time of astragaloside is 26.479min; the relative retention time of scutellaria baicalensis glycoside is 26.038min; the relative retention time of danyao glycoside is 9.862min; the relative retention time of chuanxiong saponin VI is 51.677min; the relative retention time of typha galangin is 18.489min; the relative retention time of ginsenoside Rg1 is 35.176min; the relative retention time of ginsenoside Rf is 49.757min; the relative retention time of ginsenoside Rb1 is 56.225min; the relative retention time of ginsenoside Rb2 is 60.886min; the relative retention time of ginsenoside Rc is 58.356min; the relative retention time of ginsenoside Rd is 67.053min The relative retention time of hesperidin is 27.889min; the relative retention time of nobiletin is 71.493min; the relative retention time of naringin is 24.676min; the relative retention time of mediptertin is 68.481min; the relative retention time of catechin is 7.067min; the relative retention time of epicatechin is 10.523min; the relative retention time of formononetin is 32.294min; the relative retention time of formononetin is 57.858min; the relative retention time of daidzin is 13.86min; the relative retention time of rutin is 20.283min; the relative retention time of β-sitosterol is 28.699min; the relative retention time of liquiritigenin is 36.488min.

10. The quality inspection method according to claim 1, characterized in that: The concentration of astragaloside in the reference solution was 17.6000μg / ml, the concentration of scutellaria baicalensis glycoside was 10.4500μg / ml, the concentration of dangyao glycoside was 21.1000μg / ml, the concentration of Chuanxiong saponin VI was 14.8500μg / ml, the concentration of typha galangin was 13.3500μg / ml, the concentration of ginsenoside Rg1 was 35.4500μg / ml, the concentration of ginsenoside Rf was 20.4500μg / ml, the concentration of ginsenoside Rb1 was 15.9500μg / ml, the concentration of ginsenoside Rb2 was 35.1000μg / ml, the concentration of ginsenoside Rc was 23.6000μg / ml, and the concentration of ginsenoside Rd was 15.5500μg / ml. μg / ml, the concentration of hesperidin was 4.4670μg / ml, the concentration of nobiletin was 21.9500μg / ml, the concentration of naringin was 11.5000μg / ml, the concentration of mediptertin was 8.4000μg / ml, the concentration of catechin was 14.9790μg / ml, the concentration of epicatechin was 20.4880μg / ml, the concentration of formononetin was 16.4750μg / ml, the concentration of formononetin was 9.5000μg / ml, the concentration of daidzin was 8.2400μg / ml, the concentration of rutin was 9.2500μg / ml, the concentration of β-sitosterol was 4.0400μg / ml, and the concentration of liquiritigenin was 4.4000μg / ml.

Citation Information

Patent Citations

  • Method for measuring contents of multiple components of taxillus sutchuenensis

    CN108414630A

  • Traditional Chinese medicine composition for preventing and treating recurrent abortion

    CN112870277A

  • Fingerprint spectrum construction method and detection method of kidney-nourishing and fetus-nourishing pills

    CN113884582A

  • Fingerprint spectrum construction method of novel compound aloe capsule and fingerprint spectrum

    CN115508492A

  • Method for determining contents of 17 effective components in dried orange peel by using UPLC-MS / MS (ultra performance liquid chromatography-mass spectrometry / mass spectrometry)

    CN115902028A